Palliative effect of interaperitoneal administration of triamcinolone acetonide in patients with malignant peritonitis
Not Applicable
- Conditions
- refractory patients with malignant peritonitis
- Registration Number
- JPRN-UMIN000010233
- Lead Sponsor
- Koji Takeda
- Brief Summary
o patients was entered in this study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
Not provided
Exclusion Criteria
1. bloody ascitis 2. infectious peritonitis 3. in controlled diabetes mellitus (HbA1c; more than 8.5%) 4. Pregnant or breast feeding woman 5. Not available for follow-up assesments or unable to comply with study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method